Tuttle KR - Search Results

1

Management of the diabetic patient with advanced chronic kidney disease.

Alicic RZ, Tuttle KR. Alicic RZ, et al. Among authors: tuttle kr. Semin Dial. 2010 Mar-Apr;23(2):140-7. doi: 10.1111/j.1525-139X.2010.00700.x. Epub 2010 Mar 30. Semin Dial. 2010. PMID: 20374553 Review.

2

A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition.

Tuttle KR, Anderson PW. Tuttle KR, et al. Am J Kidney Dis. 2003 Sep;42(3):456-65. doi: 10.1016/s0272-6386(03)00741-8. Am J Kidney Dis. 2003. PMID: 12955673 Review.

3

Diabetic nephropathy: implications for renal and cardiovascular outcomes.

Folan LA, Tuttle KR. Folan LA, et al. Among authors: tuttle kr. Minerva Med. 2004 Oct;95(5):385-94. Minerva Med. 2004. PMID: 15467514 Review.

4

Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: a statistical modeling perspective.

Short RA, Tuttle KR. Short RA, et al. Among authors: tuttle kr. Semin Nephrol. 2005 Jan;25(1):25-31. doi: 10.1016/j.semnephrol.2004.09.005. Semin Nephrol. 2005. PMID: 15660331 Review.

5

Implications of chronic kidney disease for dietary treatment in cardiovascular disease.

Packard DP, Milton JE, Shuler LA, Short RA, Tuttle KR. Packard DP, et al. Among authors: tuttle kr. J Ren Nutr. 2006 Jul;16(3):259-68. doi: 10.1053/j.jrn.2006.04.022. J Ren Nutr. 2006. PMID: 16825032 Review.

6

Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease.

Tuttle KR, McGill JB, Haney DJ, Lin TE, Anderson PW; PKC-DRS, PKC-DMES, and PKC-DRS 2 Study Groups. Tuttle KR, et al. Clin J Am Soc Nephrol. 2007 Jul;2(4):631-6. doi: 10.2215/CJN.00840207. Epub 2007 May 30. Clin J Am Soc Nephrol. 2007. PMID: 17699475 Clinical Trial.

7

Do agents that block the RAS truly offer renoprotective effects in early stage, nonproteinuric nephropathy?

Alicic R, Tuttle KR. Alicic R, et al. Among authors: tuttle kr. Curr Hypertens Rep. 2007 Nov;9(5):393-402. doi: 10.1007/s11906-007-0073-8. Curr Hypertens Rep. 2007. PMID: 18177587 Review.

8

Protein kinase C-beta inhibition for diabetic kidney disease.

Tuttle KR. Tuttle KR. Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S70-4. doi: 10.1016/j.diabres.2008.09.041. Diabetes Res Clin Pract. 2008. PMID: 18977550 Review.

9

Should albuminuria be a focus of antihypertensive therapy goals?

Alicic RZ, Saha SA, Short RA, Tuttle KR. Alicic RZ, et al. Among authors: tuttle kr. Curr Hypertens Rep. 2009 Oct;11(5):354-62. doi: 10.1007/s11906-009-0059-9. Curr Hypertens Rep. 2009. PMID: 19737452 Review.

10

Can comprehensive lifestyle change alter the course of chronic kidney disease?

Tuttle KR, Sunwold D, Kramer H. Tuttle KR, et al. Semin Nephrol. 2009 Sep;29(5):512-23. doi: 10.1016/j.semnephrol.2009.06.008. Semin Nephrol. 2009. PMID: 19751897 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters